PRAXIS PRECISION MEDICINES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
PRAXIS PRECISION MEDICINES, INC. (PRAX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 109.65 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 7.58K shares, a 87.98% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 102.06K shares, a 60.98% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 324.67K shares, a 73.43% decline from fiscal 2024.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.22M shares, a 479.03% increase from fiscal 2023.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 211.00K shares, a 94.68% decline from fiscal 2022.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 3.97M shares, a 96.61% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 7.58K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 109.65K shares 10-Q · filed 2026-08-06 | 109.65K shares derived: sum of 3 quarters · filed 2026-08-06 | 109.65K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 102.06K shares 10-Q · filed 2026-05-07 | 102.06K shares derived: sum of 2 quarters · filed 2026-05-07 | 102.06K shares derived: sum of 3 quarters · filed 2026-05-07 | 165.18K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-19 | 63.12K shares derived: sum of 3 quarters · filed 2026-02-19 | 324.67K shares 10-K · filed 2026-02-19 |
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-05 | 63.12K shares derived: sum of 2 quarters · filed 2025-11-05 | 324.67K shares 10-Q · filed 2025-11-05 | 350.87K shares derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-06-30 | 63.12K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | 324.67K shares 10-Q · filed 2025-08-04 | 350.87K shares derived: sum of 3 quarters · filed 2025-08-04 | 1.06M shares derived: sum of 4 quarters · filed 2025-08-04 |
| 2025-03-31 | 261.55K shares 10-Q · filed 2025-05-02 | 287.75K shares derived: sum of 2 quarters · filed 2025-05-02 | 994.65K shares derived: sum of 3 quarters · filed 2025-05-02 | 1.05M shares derived: sum of 4 quarters · filed 2025-05-02 |
| 2024-12-31 | 26.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 733.10K shares derived: sum of 2 quarters · filed 2025-02-28 | 792.90K shares derived: sum of 3 quarters · filed 2025-02-28 | 1.22M shares 10-K · filed 2025-02-28 |
| 2024-09-30 | 706.90K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | 766.70K shares derived: sum of 2 quarters · filed 2024-11-06 | 1.20M shares 10-Q · filed 2024-11-06 | -1.52M shares derived: sum of 4 quarters · filed 2024-11-06 |
| 2024-06-30 | 59.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 488.65K shares 10-Q · filed 2024-08-13 | -2.23M shares derived: sum of 3 quarters · filed 2024-08-13 | -2.11M shares derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | 428.85K shares 10-Q · filed 2024-05-13 | -2.29M shares derived: sum of 2 quarters · filed 2024-05-13 | -2.17M shares derived: sum of 3 quarters · filed 2024-05-13 | -1.99M shares derived: sum of 4 quarters · filed 2024-05-13 |
| 2023-12-31 | -2.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -2.60M shares derived: sum of 2 quarters · filed 2024-03-05 | -2.42M shares derived: sum of 3 quarters · filed 2024-03-05 | 211.00K shares 10-K · filed 2024-03-05 |
| 2023-09-30 | 112.30K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 296.69K shares derived: sum of 2 quarters · filed 2023-11-07 | 2.93M shares 10-Q · filed 2023-11-07 | 2.96M shares derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | 184.39K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 2.81M shares 10-Q · filed 2023-08-09 | 2.85M shares derived: sum of 3 quarters · filed 2023-08-09 | 2.90M shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | 2.63M shares 10-Q · filed 2023-05-11 | 2.67M shares derived: sum of 2 quarters · filed 2023-05-11 | 2.72M shares derived: sum of 3 quarters · filed 2023-05-11 | 4.97M shares derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | 36.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | 87.88K shares derived: sum of 2 quarters · filed 2023-02-07 | 2.34M shares derived: sum of 3 quarters · filed 2023-02-07 | 3.97M shares 10-K · filed 2023-02-07 |
| 2022-09-30 | 51.38K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 2.30M shares derived: sum of 2 quarters · filed 2022-11-09 | 3.93M shares 10-Q · filed 2022-11-09 | 4.31M shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 2.25M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 3.88M shares 10-Q · filed 2022-08-08 | 4.26M shares derived: sum of 3 quarters · filed 2022-08-08 | 4.35M shares derived: sum of 4 quarters · filed 2022-08-08 |
| 2022-03-31 | 1.63M shares 10-Q · filed 2022-05-09 | 2.01M shares derived: sum of 2 quarters · filed 2022-05-09 | 2.10M shares derived: sum of 3 quarters · filed 2022-05-09 | 2.51M shares derived: sum of 4 quarters · filed 2022-05-09 |
| 2021-12-31 | 374.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 470.50K shares derived: sum of 2 quarters · filed 2022-02-28 | 879.18K shares derived: sum of 3 quarters · filed 2022-02-28 | 2.02M shares 10-K · filed 2022-02-28 |
| 2021-09-30 | 95.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | 504.43K shares derived: sum of 2 quarters · filed 2021-11-03 | 1.64M shares 10-Q · filed 2021-11-03 | 1.88M shares derived: sum of 4 quarters · filed 2021-11-03 |
| 2021-06-30 | 408.68K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 1.55M shares 10-Q · filed 2021-08-16 | 1.78M shares derived: sum of 3 quarters · filed 2021-08-16 | |
| 2021-03-31 | 1.14M shares 10-Q · filed 2021-05-11 | 1.37M shares derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2020-12-31 | 234.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | 4.53M shares 10-K · filed 2021-03-17 | ||
| 2020-09-30 | 4.30M shares 10-Q · filed 2020-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |